2021
Diseases of the Fallopian Tube
Xing D, Snir O, Hui P. Diseases of the Fallopian Tube. Practical Anatomic Pathology 2021, 193-223. DOI: 10.1007/978-3-030-68608-6_8.Peer-Reviewed Original ResearchSerous tubal intraepithelial carcinomaSerous tubal intraepithelial lesionsSecretory cell outgrowthsFallopian tubeSerous carcinomaPrimary fallopian tube carcinomaHigh-grade serous carcinomaFallopian tube neoplasmsLikelihood of overdiagnosisFallopian tube carcinomaTubal intraepithelial carcinomaTubal intraepithelial lesionsNon-neoplastic lesionsSpectrum of entitiesProbable Wolffian originFemale adnexal tumorNongynecologic originEctopic pregnancyMiscellaneous tumorsIntraepithelial lesionsP53 signatureRelated complicationsChronic inflammationIntraepithelial carcinomaMetastatic carcinoma
2018
Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer
Albright BB, Black JD, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Buza N, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer. Gynecologic Oncology Reports 2018, 23: 28-33. PMID: 29387776, PMCID: PMC5771964, DOI: 10.1016/j.gore.2018.01.003.Peer-Reviewed Original ResearchLaparoscopic/robotic approachType II endometrial adenocarcinomaRisk of recurrenceDisease recurrenceFinal pathologyEndometrial adenocarcinomaFallopian tubeTumor fragmentsType II endometrial cancerRobotic approachCox proportional hazards modelHigher stage diseaseSingle institution experienceIndependent prognostic impactType IProportional hazards modelResult of traumaElectronic medical recordsCharacteristics of casesBaseline characteristicsExtensive diseaseLymphovascular invasionOverall survivalPatient comorbiditiesStage disease
2014
Genotyping Diagnosis of Nongestational Choriocarcinoma Involving Fallopian Tube and Broad Ligament
Buza N, Rutherford T, Hui P. Genotyping Diagnosis of Nongestational Choriocarcinoma Involving Fallopian Tube and Broad Ligament. International Journal Of Gynecological Pathology 2014, 33: 58-63. PMID: 24300537, DOI: 10.1097/pgp.0b013e31827cd386.Peer-Reviewed Original ResearchConceptsBroad ligamentFallopian tubePelvic lymph node metastasisMultiagent chemotherapy regimenRecurrence 26 monthsRight adnexal massRight fallopian tubeLymph node metastasisOnly necrotic tissueLast menstrual periodLarge tumor massMicroscopic examinationChemotherapy regimenEctopic pregnancyMultiagent chemotherapyNongestational choriocarcinomaPure choriocarcinomaNode metastasisPatient ageInitial diagnosisInitial presentationGestational choriocarcinomaAdnexal massesFinal diagnosisEmergency room
2011
Urinary hCG Screening in the Gynecologic Oncology Population
Richter C, Buza N, Hui P, Silasi D, Azodi M, Santin A, Rutherford T, Schwartz P. Urinary hCG Screening in the Gynecologic Oncology Population. Journal Of Gynecologic Surgery 2011, 27: 143-146. DOI: 10.1089/gyn.2010.0048.Peer-Reviewed Original ResearchGestational trophoblastic diseasePositive urine pregnancy testUrine pregnancy testGynecologic malignanciesUrinary hCGTrophoblastic diseasePregnancy testHuman chorionic gonadotropin testingClear cell ovarian carcinomaGynecologic oncology clinicGynecologic oncology populationRetrospective chart reviewHCG testingChart reviewNonpregnant patientsConsecutive patientsOncology populationPrimary peritonealOncology clinicVaginal carcinomaNongynecologic malignanciesUterine cancerFallopian tubeOvarian carcinomaOvarian cancer
2010
Tumors of Fallopian Tube and Broad Ligament
Chhieng D, Hui P. Tumors of Fallopian Tube and Broad Ligament. Current Clinical Pathology 2010, 139-143. DOI: 10.1007/978-1-60761-164-6_9.Peer-Reviewed Original ResearchFallopian tubeBroad ligamentBenign tumorsBilateral nodular lesionsEctopic adrenal restsSalpingitis isthmica nodosaTubo-ovarian adhesionsSmooth muscle hypertrophyTumor-like conditionsCommon benign tumorRare benign tumorPeutz-Jeghers syndromeOvarian primaryChronic salpingitisEctopic pregnancyTubal pregnancyPelvic symptomsTubal mucosaAdrenal restsBorderline tumorsCystic alterationsPapillary lesionsNodular lesionsCommon findingMucinous metaplasia
2004
Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation
Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecologic Oncology 2004, 95: 469-473. PMID: 15581948, DOI: 10.1016/j.ygyno.2004.08.030.Peer-Reviewed Original ResearchConceptsUterine papillary serous carcinomaStage IA patientsResidual uterine diseaseAdvanced stage uterine papillary serous carcinomaIA patientsUterine diseaseSerous cancerUterine papillary serous cancerComplete surgical stagingObstetrics stage IAPapillary serous cancerDifferent therapeutic optionsPapillary serous carcinomaPlatinum-based chemoradiationMore effective treatmentsLocoregional diseaseHysterectomy specimenStage IAStage IIIAStage IIICSurgical stagingExtrauterine metastasesSerous carcinomaTherapeutic optionsFallopian tube